Combined Enzymatic and Antioxidative Treatment Reduces Ischemia-Reperfusion Injury in Rabbit Skeletal Muscle

Journal of Surgical Research

Volumn 133, Issue 2, 2006, Pages 150-158

  Neumayer, Christoph ^a   Fügl, Alexander ^a   Nanobashvili, Josef ^a   Blumer, Roland ^a   Punz, Andreas ^a   Gruber, Helmut ^a   Polterauer, Peter ^a   Huk, Ihor ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

bromelain; edema; flavonoids; hydrolytic enzymes; ischemia reperfusion; microcirculation; Phlogenzym ; rutin; skeletal muscle; trypsin

Indexed keywords

ANTIOXIDANT; BROMELAIN; LIPID PEROXIDE; MALONALDEHYDE; PHLOGENZYM; POTASSIUM; RUTOSIDE; TRYPSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY FLOW; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG FORMULATION; EDEMA; ELECTRON MICROSCOPY; HEMODYNAMIC MONITORING; LASER FLOWMETER; LIPID PEROXIDATION; MICROVASCULATURE; MORPHOMETRICS; MUSCLE INJURY; MUSCLE ISCHEMIA; NONHUMAN; PH; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BROMELAINS; CAPILLARIES; DRUG COMBINATIONS; HYDROGEN-ION CONCENTRATION; LIPID PEROXIDES; MALE; MALONDIALDEHYDE; MICROCIRCULATION; MICROSCOPY, ELECTRON; MUSCLE FIBERS; MUSCLE, SKELETAL; POTASSIUM; RABBITS; REPERFUSION INJURY; RUTIN; THIOBARBITURATES; TRYPSIN;

EID: 33646817081     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2005.12.005     Document Type: Article

References (50)

1. Nanobashvili J., Neumayer C., Fuegl A., et al. Ischemia/reperfusion injury of skeletal musclemechanisms, morphology, treatment strategies, and clinical applications. Eur Surg 34 (2002) 83
2. -) after ischemia and reperfusion. J Surg Res 50 (1991) 565
3. 1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release. Shock 14 (2000) 234
4. Huk I., Nanobashvili J., Neumayer C., et al. L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 96 (1997) 667
5. Choudhury N.A., Sakaguchi S., Koyano K., et al. Free radical injury in skeletal muscle ischemia and reperfusion. J Surg Res 51 (1991) 392
6. Ikezawa T., Nishikima N., and Oba Y. Lipid peroxides in the mechanism of ischemia/reperfusion injury in skeletal muscle-experimental studies. Vasc Surg 27 (1993) 191
7. Gute D.C., Ishida T., Yarimizu K., et al. Inflammatory responses to ischemia and reperfusion in skeletal muscle. Mol Cell Biochem 179 (1998) 169
8. Nanobashvili J., Neumayer C., Fuegl A., et al. Development of "no-reflow" phenomenon in ischemia/reperfusion injury. Failure of active vasomotility and not simply passive vasoconstriction. Eur Surg Res 35 (2003) 417
9. Quinones-Baldrich W.J., Chervu A., Hernandez J.J., et al. Skeletal muscle function after ischemia. "no reflow" versus reperfusion injury. J Surg Res 51 (1991) 5
10. Oliver J.A. Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J Cell Physiol 151 (1992) 506
11. Hallstroem S., Gasser H., Neumayer C., et al. S-nitroso human serum albumin treatment reduces ischemia/reperfusion injury in skeletal muscle via nitric oxide release. Circulation 105 (2002) 3032
12. Punz A., Nanobashvili J., Neumayer C., et al. Multivitamin administration before ischemia reduces ischemia-reperfusion injury in rabbit skeletal muscle. Clin Nutr 18 (1999) 219
13. Neumayer C., Nanobashvili J., Fuegl A., et al. α-tocopherol pretreatment reduces ischaemia/reperfusion injury in rabbit skeletal muscle. Eur Surg 34 (2002) 90
14. Huk I., Brovkovych V., Nanobashvili J., et al. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischemia-reperfusion injury. an experimental study. Br J Surg 85 (1998) 1080
15. Chen Y.T., Zheng R.L., Jia Z.J., et al. Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 9 (1990) 19
16. Nanobashvili J., Neumayer C., Fuegl A., et al. Combined L-arginine and antioxidative vitamin treatment mollifies ischemia-reperfusion injury of skeletal muscle. J Vasc Surg 39 (2004) 868
17. Latha B., Ramakrishnan M., Jayaraman V., et al. The efficacy of trypsin. chymotrypsin preparation in the reduction of oxidative damage during burn injury. Burns 24 (1998) 532
18. Metzig C., Grabowska E., Eckert K., et al. Bromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivo. In Vivo 13 (1999) 7
19. Clavien P.A., Harvey P.R., Sanabria J.R., et al. Lymphocyte adherence in the reperfused rat liver. mechanisms and effects. Hepatology 17 (1993) 131
20. McLean P.G., Aston D., Sarkar D., et al. Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ Res 90 (2002) 465
21. Munzig E., Eckert K., Harrach T., et al. Bromelain protease F9 reduces the CD44 mediated adhesion of human peripheral blood lymphocytes to human umbilical vein endothelial cells. FEBS Lett 351 (1994) 215
22. Livio M., Bertoni M.P., De Gaetano G., et al. Effect of bromelain on fibrinogen level, prothrombin complex factors and platelet aggregation in the rat-a preliminary report. Drugs Exp Clin Res 4 (1978) 49
23. Guggenbichler J.P. Einfluß hydrolytischer Enzyme auf die Thrombusbildung und Thrombolyse. Med Welt 39 (1988) 277
24. Maurer H.R. Bromelain. biochemistry, pharmacology and medical use. Cell Mol Life Sci 58 (2001) 1234
25. Lebeau J., Neviere R., and Cotelle N. Beneficial effects of different flavonoids on functional recovery after ischemia and reperfusion in isolated rat heart. Bioorg Med Chem Lett 11 (2001) 23
26. De Celle T., Heeringa P., Strzelecka A.E., et al. Sustained protective effects of 7-monohydroxyethylrutoside in an in vivo model of cardiac ischemia-reperfusion. Eur J Pharmacol 494 (2004) 205
27. Gupta R., Singh M., and Sharma A. Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. Pharmacol Res 48 (2003) 209
28. Shahid S.K., Turakhia N.H., Kundra M., et al. Efficacy and safety of phlogenzym-a protease formulation, in sepsis in children. J Assoc Physicians India 50 (2002) 527
29. Redl H., Gasser H., Hallström S., et al. Radical related cell in jury. In: G S., and H R. (Eds). Pathophysiology of Shock, Sepsis and Organ Failure (1993), Springer Verlag, Berlin, Heidelberg 92-110
30. Seyr M., and Mutz N.J. Permeability changes. In: G S., and H R. (Eds). Pathophysiology of Shock, Sepsis and Organ Failure (1993), Springer Verlag, Berlin, Heidelberg 176-193
31. Beerthuizen G.I. Response of the microcirculation. tissue oxygenation. In: G S., and H R. (Eds). Pathophysiology of Shock, Sepsis and Organ Failure (1993), Springer Verlag, Berlin, Heidelberg 230-241
32. Huk I., Nanobashvili J., Punz A., et al. Influence of a short-term acute ischemia and reperfusion on skeletal muscle metabolism and morphology in rabbits. Int J Angiol 5 (1996) 59
33. Koch M, Seidel T, Stiftner H, et al., eds. VIDAL® Arzneimittelkompendium Österreich 2003. Innsbruck, Arzneimittelinformation VIDAL GmbH, 2003;1932-1933.
34. Steffen C., and Menzel J. Grundlagenuntersuchung zur Enzymtherapie bei Immunkomplexkrankheiten. Wien Klin Wochenschr 97 (1985) 376
35. Wong S.H., Knight J.A., Hopfer S.M., et al. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33 (1987) 214
36. Chan R.K., Austen W.G., Ibrahim S., et al. Reperfusion injury to skeletal muscle affects primarily type II muscle fibers. J Surg Res 122 (2004) 54
37. Klingler A. Statistical methods in surgical research. a practical guide. Eur Surg 36 (2004) 80
38. Robak J., and Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 37 (1998) 837
39. Cotelle N., Bernier J.L., Catteau J.P., et al. Antioxidant properties of hydroxy-flavones. Free Radic Biol Med 20 (1996) 35
40. Afanas'ev I.B., Dorozhko A.I., Brodskii A.V., et al. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38 (1989) 1763
41. Jovanovic S., Steenken S., Tosic M., et al. Flavonoids as antioxidants. J Am Chem Soc 116 (1994) 4846
42. Grisotto P.C., dos Santos A.C., Coutinho-Netto J., et al. Indicators of oxidative injury and alterations of the cell membrane in the skeletal muscle of rats submitted to ischemia and reperfusion. J Surg Res 92 (2000) 1
43. Rice-Evans C.A., Miller N.J., Bolwell P.G., et al. The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic Res 22 (1995) 375
44. Lemasters J.J., Bond J.M., Chacon E., et al. The pH paradox in ischemia-reperfusion injury to cardiac myocytes. EXS 76 (1996) 99
45. Wolff S.P., Garner A., and Dean R.T. Free radicals, lipids, and protein degradation. Trends Biochem Sci 11 (1986) 27
46. Furukawa T., Fan Z., Sawanobori T., et al. Modification of the adenosine 5′-triphosphate-sensitive K+ channel by trypsin in guinea-pig ventricular myocytes. J Physiol 466 (1993) 707
47. Blackburn W.D., Heck L.W., and Wallace R.W. The bioflavonoid quercetin inhibits neutrophil degranulation, superoxide production, and the phosphorylation of specific neutrophil proteins. Biochem Biophys Res Commun 144 (1987) 1229
48. Vellini M., Desideri D., Milanese A., et al. Possible involvement of eicosanoids in the pharmacological action of bromelain. Drug Res 36 (1986) 110
49. Ojanen R., Kaukinen L., Seppala E., et al. Single dose of acetylsalicylic acid prevents thromboxane release after tourniquet ischemia. J Trauma 54 (2003) 986
50. Miller J., and Ophers A. The increased proteolytic activity of human blood serum after the oral administration of bromelin. Exp Med Surg 22 (1964) 277